logo
Plus   Neg
Share
Email

PNM Resources Names Don Tarry To Succeed Chuck Eldred As CFO - Quick Facts

Energy holding company PNM Resources, Inc. (PNM) announced Wednesday that Chuck Eldred, currently Executive Vice President and Chief Financial Officer, has been named Executive Vice President, Corporate Development and Finance.

In his new role, Eldred will now be focused on achieving the company's key strategic objectives including the transformation to a carbon-free generation portfolio at PNM, increased investment in TNMP infrastructure and overseeing the successful transition of leaders within the finance organization.

Don Tarry, currently Vice President, Controller and Treasurer, has been named Senior Vice President and CFO of PNM Resources. He joined PNM Resources in 1996 and was previously Vice President of Customer Service and Chief Information Officer.

Additionally, Lisa Eden, currently Vice President of Human Resources and previously Vice President and Treasurer, has been named Vice President, Chief Information Officer. She succeeds Mike Mertz, who has been named Vice President and Treasurer. Henry Monroy has been named Vice President and Corporate Controller.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
RELATED NEWS
Follow RTT